Drug Trial Radar · NCT06834789
A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)
Last checked: Nov 20, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
132
Actual
Start
Feb 18, 2025
Primary completion
Nov 3, 2025
Study completion Nov 3, 2025
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Feb 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this Phase 1 study is to assess the safety and efficacy of single treatment of AGN-151586 and of OnabotulinumtoxinA in the glabellar complex of participants with moderate to severe glabellar lines (GL).
Conditions
- Glabellar Lines
Interventions
AGN-151586Drug
Intramuscular injection
OnabotulinumtoxinADrug
Intramuscular injection
PlaceboDrug
Intramuscular injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Adverse Events (AEs)Time frame: Up to approximately 10.4 months
- Number of Participants with the Presence of Binding and Neutralizing Antidrug Antibodies to AGN-151586 and/or OnabotulinumtoxinATime frame: Up to approximately 10.4 months
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Investigate MD /ID# 270771
Scottsdale, Arizona
Eye Research Foundation /ID# 270827
Newport Beach, California
Marcus Facial Plastic Surgery /ID# 270770
Redondo Beach, California
Skin Research Institute LLC /ID# 270831
Coral Gables, Florida
Skincare Physicians /ID# 271018
Chestnut Hill, Massachusetts
Wilmington Dermatology Center /ID# 270828
Wilmington, North Carolina
Austin Institute for Clinical Research - Pflugerville /ID# 270834
Pflugerville, Texas
SkinDC /ID# 270932
Arlington, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.